SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial - Concepedia

Concepedia

Publication | Open Access

SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial

DOI Full Paper Access

46

Citations

25

References

2024

Year

Brittany L Ober Shepherd, Paul T Scott, Jack N Hutter, Christine U. Lee, Melanie McCauley, Ivelese Guzman, Christopher Bryant, Sarah McGuire, Jessie K. Kennedy, Wei-Hung Chen,

The Lancet Microbe

Abstract

US Department of Defense, Defense Health Agency.

References

	Year	Citations

Page 1